Tango Therapeutics Hits Day High with 36.28% Surge in Stock Price

Tango Therapeutics, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, gaining 36.28% as of March 5, 2026. The stock reached an intraday high of USD 16.97, reflecting a strong performance compared to the S&P 500, which saw a modest increase of 0.78% on the same day. Over the past week, Tango Therapeutics has surged by 47.63%, and its one-month performance stands at an impressive 40.84%. The company has demonstrated remarkable growth over the past year, with a staggering 705.26% increase, significantly outpacing the S&P 500's 18.89% gain during the same period. Year-to-date, the stock has risen by 89.95%, further solidifying its position in the market. Key financial metrics highlight the company's robust performance, including a remarkable 1591.64% growth in net sales, with the latest quarterly net sales reaching USD 53.81 million. Additionally, the operating profit for the quarter hit a record USD 14.63 million. With high institutional holdings at 100%, Tango Therapeutics continues to showcase its market strength and resilience.